Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary…

Overview of attention for article published in BMC Cancer, June 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 26,568 followers.

Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer Read the CRAIN study protocol published in #BMCCancer @BMC_series #ISRCTN: https://t.co/ZuqFrvyaK4 https://t.co/56ePXQTyY7

RT @achoud72: 👀#openaccess #protocol of #CRT plus #XIAPi for #cervixcancer. Phase Ib/II trial led by #WhereisHoskin & @SouthamptonCTU Recru…

Fantastic work from the CRAIN trial team to get this protocol paper published. Well done everyone 👏👏

RT @achoud72: 👀#openaccess #protocol of #CRT plus #XIAPi for #cervixcancer. Phase Ib/II trial led by #WhereisHoskin & @SouthamptonCTU Recru…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.